Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Departament de Medicina

Conjunt de dades

1 Article

1 resultats

2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
Heidenreich, A., Gillessen, S., Heinrich, D., Keizman, D., O'Sullivan, J. M., Carles, J., Wirth, M., Miller, K., Reeves, J., Seger, M., Nilsson, S. & Saad, F., 7 de gen. 2019, In: BMC Cancer. 19, 1, 12.
Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

Accés Obert
46 Cites (Scopus)